[HTML][HTML] Cellular immune response to COVID-19 and potential immune modulators

X Zhou, Q Ye - Frontiers in immunology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …

SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure

AR Thierry, B Roch - Clinical Science, 2020 - portlandpress.com
We demonstrate that the general clinical conditions, risk factors and numerous pathological
and biological features of COVID-19 are analogous with various disorders caused by the …

Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review

A Yarmohammadi, M Yarmohammadi, S Fakhri… - European journal of …, 2021 - Elsevier
As an emerging global health crisis, coronavirus disease 2019 (COVID-19) has been
labeled a worldwide pandemic. Growing evidence is revealing further pathophysiological …

[HTML][HTML] Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19

E Andreakos, M Papadaki, CN Serhan - Allergy, 2021 - ncbi.nlm.nih.gov
Coronavirus disease-19 (COVID-19) is a new disease caused by SARS-CoV-2. Since the
beginning of 2020, it has become one of the main challenges of our times, causing a high …

[HTML][HTML] Immune response, inflammation, and the clinical spectrum of COVID-19

LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …

[HTML][HTML] After 62 years of regulating immunity, dexamethasone meets COVID-19

DW Cain, JA Cidlowski - Nature Reviews Immunology, 2020 - nature.com
Six months into the COVID-19 pandemic, effective treatments have been frustratingly sparse.
The RECOVERY clinical trial, however, revealed that treatment with dexamethasone, a …

Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

N Ebrahimi, S Aslani, F Babaie… - International …, 2020 - Elsevier
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) is responsible for recent
ongoing public health emergency in the world. Sharing structural and behavioral similarities …

The amount of cytokine-release defines different shades of Sars-Cov2 infection

S Bindoli, M Felicetti, P Sfriso… - … Biology and Medicine, 2020 - journals.sagepub.com
The recent outbreak of coronavirus disease (COVID 19), spreading from China all around
the world in early 2020, has led scientists to investigate the immuno-mediated mechanisms …

Understanding COVID-19 pandemic: molecular mechanisms and potential therapeutic strategies. An evidence-based review

R Hanna, S Dalvi, T Sălăgean, ID Pop… - Journal of …, 2021 - Taylor & Francis
Abstract Initially, the SARS-CoV-2 virus was considered as a pneumonia virus; however, a
series of peer reviewed medical papers published in the last eight months suggest that this …

Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions

R Noroozi, W Branicki, K Pyrc, PP Łabaj, E Pospiech… - Cytokine, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global
pandemic in early 2020. The infection has been associated with a wide range of clinical …